Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.

In a Phase I study, melphalan 140 mg/m2 was administered to 8 patients with disseminated malignant melanoma. Marrow was removed from the patients immediately before melphalan administration and returned i.v. 8 h later. Studies on marrow culture and melphalan pharmacokinetics predicted that this was...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McElwain, T. J., Hedley, D. W., Burton, G., Clink, H. M., Gordon, M. Y., Jarman, M., Juttner, C. A., Millar, J. L., Milsted, R. A., Prentice, G., Smith, I. E., Spence, D., Woods, M.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1979
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2009972/
https://ncbi.nlm.nih.gov/pubmed/383125
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars